Literature DB >> 9847319

Diverse gene junctions of respiratory syncytial virus modulate the efficiency of transcription termination and respond differently to M2-mediated antitermination.

R W Hardy1, S B Harmon, G W Wertz.   

Abstract

The ability of the diverse gene junctions of respiratory syncytial (RS) virus to signal the termination of transcription was analyzed. Nine dicistronic subgenomic replicons of RS virus were constructed; each contained one of the RS virus gene junctions in its natural upstream and downstream sequence context. The RNA synthesis activities of these subgenomic replicons were analyzed in the absence and presence of the M2 protein, which we showed previously to function as a transcription antiterminator. Our data showed that the efficiency with which the polymerase terminated transcription was affected by the gene junction that it encountered. The M2 protein significantly decreased the efficiency of the termination of transcription, resulting in increased levels of readthrough transcription at all the gene junctions. The diverse gene junctions fell into three broad groups with respect to their ability to signal transcription termination. One group of gene junctions (NS1/NS2, NS2/N, M2/L, and L/trailer) showed inefficient termination in the absence or the presence of the M2 protein. A second group of gene junctions (N/P, P/M, M/SH, SH/G, and G/F) terminated transcription efficiently. The SH/G gene junction terminated transcription with the greatest efficiency and produced low levels of readthrough transcripts in the absence or the presence of the M2 protein, correlating with the absence of SH/G polycistronic transcripts in RS virus-infected cells. The F/M2 gene junction was particularly sensitive to the M2 protein: it efficiently signaled termination in the absence of the M2 protein but produced high levels of readthrough transcripts in the presence of the M2 protein. This result suggests that the M2 protein may regulate its own production by negative feedback. The data presented here show that the different gene junctions of RS virus do modulate RS virus transcription termination. The M2 protein reduced termination at all gene junctions. The magnitude of antitermination due to the M2 protein, however, varied at the different gene junctions. The data presented here indicate that the mechanism for the regulation of RS virus gene expression is more complex than was previously appreciated.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9847319      PMCID: PMC103820          DOI: 10.1128/JVI.73.1.170-176.1999

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  cis-Acting signals involved in termination of vesicular stomatitis virus mRNA synthesis include the conserved AUAC and the U7 signal for polyadenylation.

Authors:  J N Barr; S P Whelan; G W Wertz
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  The structurally diverse intergenic regions of respiratory syncytial virus do not modulate sequential transcription by a dicistronic minigenome.

Authors:  L Kuo; R Fearns; P L Collins
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

Review 3.  Transcription antitermination: the lambda paradigm updated.

Authors:  D I Friedman; D L Court
Journal:  Mol Microbiol       Date:  1995-10       Impact factor: 3.501

4.  Analysis of the gene start and gene end signals of human respiratory syncytial virus: quasi-templated initiation at position 1 of the encoded mRNA.

Authors:  L Kuo; R Fearns; P L Collins
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

5.  Increased expression of the N protein of respiratory syncytial virus stimulates minigenome replication but does not alter the balance between the synthesis of mRNA and antigenome.

Authors:  R Fearns; M E Peeples; P L Collins
Journal:  Virology       Date:  1997-09-15       Impact factor: 3.616

6.  Transcription elongation factor of respiratory syncytial virus, a nonsegmented negative-strand RNA virus.

Authors:  P L Collins; M G Hill; J Cristina; H Grosfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

7.  The use of intensifying screens or organic scintillators for visualizing radioactive molecules resolved by gel electrophoresis.

Authors:  R A Laskey
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

8.  Polyadenylation of vesicular stomatitis virus mRNA dictates efficient transcription termination at the intercistronic gene junctions.

Authors:  L N Hwang; N Englund; A K Pattnaik
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

9.  Effects of mutations in the gene-start and gene-end sequence motifs on transcription of monocistronic and dicistronic minigenomes of respiratory syncytial virus.

Authors:  L Kuo; H Grosfeld; J Cristina; M G Hill; P L Collins
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

10.  The product of the respiratory syncytial virus M2 gene ORF1 enhances readthrough of intergenic junctions during viral transcription.

Authors:  R W Hardy; G W Wertz
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

View more
  47 in total

1.  Increased readthrough transcription across the simian virus 5 M-F gene junction leads to growth defects and a global inhibition of viral mRNA synthesis.

Authors:  G D Parks; K R Ward; J C Rassa
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

2.  Respiratory syncytial virus that lacks open reading frame 2 of the M2 gene (M2-2) has altered growth characteristics and is attenuated in rodents.

Authors:  H Jin; X Cheng; H Z Zhou; S Li; A Seddiqui
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Association of respiratory syncytial virus M protein with viral nucleocapsids is mediated by the M2-1 protein.

Authors:  Dongsheng Li; David A Jans; Phillip G Bardin; Jayesh Meanger; John Mills; Reena Ghildyal
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

4.  Respiratory syncytial virus M2-1 protein requires phosphorylation for efficient function and binds viral RNA during infection.

Authors:  T L Cartee; G W Wertz
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

5.  Profilin is required for optimal actin-dependent transcription of respiratory syncytial virus genome RNA.

Authors:  E Burke; N M Mahoney; S C Almo; S Barik
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

6.  Analysis of the highly diverse gene borders in Ebola virus reveals a distinct mechanism of transcriptional regulation.

Authors:  Kristina Brauburger; Yannik Boehmann; Yoshimi Tsuda; Thomas Hoenen; Judith Olejnik; Michael Schümann; Hideki Ebihara; Elke Mühlberger
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

7.  Inhibitors of respiratory syncytial virus replication target cotranscriptional mRNA guanylylation by viral RNA-dependent RNA polymerase.

Authors:  Michel Liuzzi; Stephen W Mason; Mireille Cartier; Carol Lawetz; Robert S McCollum; Nathalie Dansereau; Gordon Bolger; Nicole Lapeyre; Yvon Gaudette; Lisette Lagacé; Marie-Josée Massariol; Florence Dô; Paul Whitehead; Lyne Lamarre; Erika Scouten; Josée Bordeleau; Serge Landry; Jean Rancourt; Gulrez Fazal; Bruno Simoneau
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

8.  Ebola virus VP30-mediated transcription is regulated by RNA secondary structure formation.

Authors:  Michael Weik; Jens Modrof; Hans-Dieter Klenk; Stephan Becker; Elke Mühlberger
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

9.  Interaction between human respiratory syncytial virus (RSV) M2-1 and P proteins is required for reconstitution of M2-1-dependent RSV minigenome activity.

Authors:  Stephen W Mason; Erika Aberg; Carol Lawetz; Rachel DeLong; Paul Whitehead; Michel Liuzzi
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 10.  Animal pneumoviruses: molecular genetics and pathogenesis.

Authors:  Andrew J Easton; Joseph B Domachowske; Helene F Rosenberg
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.